LIM
Lagoda Investment Management Portfolio holdings
AUM
$177M
1-Year Return
46.81%
This Quarter Return
+3.32%
1 Year Return
+46.81%
3 Year Return
+194.86%
5 Year Return
+427.13%
10 Year Return
+1,154.94%
AUM
$375M
AUM Growth
–
Cap. Flow
+$375M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
68.18%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$37.9M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$37.1M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
$26M |
| 4 |
Novo Nordisk
NVO
|
$25.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$24.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 46.56% |
| 2 | Financials | 21.42% |
| 3 | Communication Services | 6.63% |
| 4 | Materials | 5.99% |
| 5 | Technology | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P 500 ETF Trust
SPY
$660B
| $321K | 0.09% |
+1,563
| New | +$321K |
|
27
CarMax
KMX
$9.03B
| $292K | 0.08% |
+4,380
| New | +$292K |
|
|
XEC
28
DELISTED
CIMAREX ENERGY CO
XEC
| $186K | 0.05% |
+1,750
| New | +$186K |
|
29
Nucor
NUE
$33.2B
| $172K | 0.05% |
+3,500
| New | +$172K |
|
|
NATI
30
DELISTED
National Instruments Corp
NATI
| $172K | 0.05% |
+5,540
| New | +$172K |
|
31
NetApp
NTAP
$23.6B
| $166K | 0.04% |
+4,000
| New | +$166K |
|
32
CME Group
CME
$96.2B
| $109K | 0.03% |
+1,232
| New | +$109K |
|
33
Apple
AAPL
$3.54T
| $104K | 0.03% |
+3,780
| New | +$104K |
|
34
Chevron
CVX
$320B
| $84K | 0.02% |
+750
| New | +$84K |
|
35
Pfizer
PFE
$139B
| $58K | 0.02% |
+1,977
| New | +$58K |
|
36
Fidelity National Information Services
FIS
$36B
| $41K | 0.01% |
+666
| New | +$41K |
|
37
RTX Corp
RTX
$212B
| $40K | 0.01% |
+550
| New | +$40K |
|
38
AB InBev
BUD
$116B
| $38K | 0.01% |
+340
| New | +$38K |
|
39
AbbVie
ABBV
$375B
| $32K | 0.01% |
+491
| New | +$32K |
|
40
Abbott
ABT
$232B
| $29K | 0.01% |
+640
| New | +$29K |
|
41
Archer Daniels Midland
ADM
$29.6B
| $26K | 0.01% |
+500
| New | +$26K |
|
42
Phillips 66
PSX
$53.3B
| $24K | 0.01% |
+332
| New | +$24K |
|
43
GSK
GSK
$79.3B
| $21K | 0.01% |
+400
| New | +$21K |
|
44
Dominion Energy
D
$50B
| $15K | ﹤0.01% |
+200
| New | +$15K |
|
45
ConocoPhillips
COP
$120B
| $12K | ﹤0.01% |
+2,268
| New | +$12K |
|
46
Zimmer Biomet
ZBH
$20.9B
| $10K | ﹤0.01% |
+93
| New | +$10K |
|
47
Bristol-Myers Squibb
BMY
$95.4B
| $6K | ﹤0.01% |
+100
| New | +$6K |
|